{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:18Z","timestamp":1791295758556,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1742,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Unit of Lifestyle, Virus and Genes, Danish Cancer Society Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1093\/annonc\/mdu578","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T04:45:30Z","timestamp":1419396330000},"page":"787-792","source":"Crossref","is-referenced-by-count":52,"title":["Low-dose aspirin use and the risk of ovarian cancer in Denmark"],"prefix":"10.1016","volume":"26","author":[{"given":"L.","family":"Baandrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dehlendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdu578_bb0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu578_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu578_bb0020","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu578_bb0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu578_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/aogs.12069","article-title":"Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies","volume":"92","author":"Baandrup","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1093\/annonc\/mdu578_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdu578_bb0040","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ijc.28823","article-title":"Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative","volume":"135","author":"Brasky","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"7 Suppl","key":"10.1093\/annonc\/mdu578_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1403494811399957","article-title":"Danish registers on aspects of reproduction","volume":"39","author":"Blenstrup","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"10.1093\/annonc\/mdu578_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"10.1093\/annonc\/mdu578_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"10.1093\/annonc\/mdu578_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"10.1093\/annonc\/mdu578_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1403494810394715","article-title":"Danish Education Registers","volume":"39","author":"Jensen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"10.1093\/annonc\/mdu578_bb0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1093\/annonc\/mdu578_bb0080","series-title":"Modern Epidemiology","author":"Rothman","year":"2008"},{"key":"10.1093\/annonc\/mdu578_bb0085","series-title":"Cancer Epidemiology and Prevention","article-title":"Ovarian cancer","author":"Hankinson","year":"2006"},{"key":"10.1093\/annonc\/mdu578_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju111","article-title":"Prescription use of paracetamol and risk for ovarian cancer in Denmark","volume":"106","author":"Baandrup","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdu578_bb0095","series-title":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing","author":"R Development Core Team","year":"2013"},{"key":"10.1093\/annonc\/mdu578_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/EDE.0b013e3182456ad3","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer","volume":"23","author":"Lo-Ciganic","year":"2012","journal-title":"Epidemiology"},{"key":"10.1093\/annonc\/mdu578_bb0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/1055-9965.EPI-09-0976","article-title":"Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study","volume":"19","author":"Prizment","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdu578_bb0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.ede.0000190538.55645.f8","article-title":"Analgesic drug use and risk of ovarian cancer","volume":"17","author":"Schildkraut","year":"2006","journal-title":"Epidemiology"},{"key":"10.1093\/annonc\/mdu578_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(97)08064-1","article-title":"Over-the-counter analgesics and risk of ovarian cancer","volume":"351","author":"Cramer","year":"1998","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdu578_bb0120","first-page":"933","article-title":"A case-control study of analgesic use and ovarian cancer","volume":"9","author":"Rosenberg","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdu578_bb0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1592\/phco.22.5.303.33189","article-title":"Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer","volume":"22","author":"Meier","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1093\/annonc\/mdu578_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.11538","article-title":"Medication use and risk of ovarian carcinoma: a prospective study","volume":"108","author":"Lacey","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0135","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s10552-010-9602-x","article-title":"Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk","volume":"21","author":"Lurie","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mdu578_bb0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1600-0412.2012.01472.x","article-title":"Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study","volume":"91","author":"Ammundsen","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1093\/annonc\/mdu578_bb0145","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1023\/A:1008373616424","article-title":"Aspirin and ovarian cancer: an Italian case-control study","volume":"11","author":"Tavani","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdu578_bb0150","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/pmed.2001.0945","article-title":"Aspirin and epithelial ovarian cancer","volume":"33","author":"Akhmedkhanov","year":"2001","journal-title":"Prev Med"},{"key":"10.1093\/annonc\/mdu578_bb0155","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/sj.bjc.6604392","article-title":"Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity","volume":"98","author":"Wernli","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0160","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1055-9965.EPI-12-0390-T","article-title":"Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort","volume":"21","author":"Setiawan","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdu578_bb0165","first-page":"903","article-title":"Regular use of analgesic drugs and ovarian cancer risk","volume":"10","author":"Moysich","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdu578_bb0170","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/A:1016380917625","article-title":"Aspirin, other NSAIDs, and ovarian cancer risk (United States)","volume":"13","author":"Fairfield","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mdu578_bb0175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0180","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwp062","article-title":"Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts","volume":"169","author":"Pinheiro","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1093\/annonc\/mdu578_bb0185","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s10552-012-0063-2","article-title":"Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review","volume":"23","author":"Murphy","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mdu578_bb0190","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6600760","article-title":"A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin","volume":"88","author":"Friis","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0195","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/aje\/kwn082","article-title":"Analgesic drug use and risk of epithelial ovarian cancer","volume":"167","author":"Hannibal","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1093\/annonc\/mdu578_bb0200","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/ijc.24091","article-title":"Markers of inflammation and risk of ovarian cancer in Los Angeles County","volume":"124","author":"Wu","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0205","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdu578_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdu578_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdu578_bb0220","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11912-013-0351-3","article-title":"Role of aspirin in cancer prevention","volume":"15","author":"Thorat","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1093\/annonc\/mdu578_bb0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1093\/annonc\/mdu578_bb0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0235","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/bjc.2011.289","article-title":"Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?","volume":"105","author":"Langley","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdu578_bb0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CLEP.S59156","article-title":"Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999\u20132012","volume":"6","author":"Schmidt","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1093\/annonc\/mdu578_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0773.1994.tb01089.x","article-title":"Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction)","volume":"74","author":"Winther","year":"1994","journal-title":"Pharmacol Toxicol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419314498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419314498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/4\/787\/16699192\/mdu578.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:47:33Z","timestamp":1624520853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419314498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0923753419314498"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu578","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}